New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review.
Curr Oncol
; 29(4): 2835-2847, 2022 04 17.
Article
in English
| MEDLINE | ID: covidwho-1792785
ABSTRACT
This review of the meaningful data from 2021 on cervical, endometrial, and ovarian cancers aims to provide an update of the most clinically relevant studies presented at important oncologic congresses during the year (the American Society of Clinical Oncology (ASCO) Annual Meeting, the European Society for Medical Oncology (ESMO) Congress and the Society of Gynecologic Oncology (SGO) Annual Meeting). Despite the underlying existence of the COVID-19 pandemic, the last year has been notable in terms of research, with significant and promising advances in gynecological malignancies. Several major studies reporting the effects of innovative therapies for patients with cervical, endometrial, and ovarian cancers might change the medical practice in the future.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
COVID-19
/
Gynecology
Type of study:
Prognostic study
Limits:
Female
/
Humans
Language:
English
Journal:
Curr Oncol
Year:
2022
Document Type:
Article
Affiliation country:
Curroncol29040231
Similar
MEDLINE
...
LILACS
LIS